Results 121 to 130 of about 1,862 (162)

Serum p-tau217 Is a Prognostic Indicator of Cognitive Impairment in Idiopathic REM Sleep Behavior Disorder. [PDF]

Ann Neurol
Yan S, Sahoo A, Zerenner T, Marek K, Sommerauer M, Oertel W, Hu MT, Tofaris GK.   +7 more
europepmc   +1 more source

CYP450 Constraints in Infants: A Multidomain Convergence Framework for Investigating Mechanistic Vulnerability. [PDF]

Int J Med Sci
Goldman GS.
europepmc   +1 more source

Cholinergic white matter pathways integrity in prodromal and early manifest Lewy body disease. [PDF]

Brain Commun
Eisenstein T, Groenewald K, van Hillegondsberg L, Al Hajraf F, Zerenner T, Lawton MA, Ben-Shlomo Y, Griffanti L, Hu MTM, Klein JC.   +9 more
europepmc   +1 more source

Free water predicts dementia with Lewy bodies in isolated REM sleep behavior disorder. [PDF]

Alzheimers Dement
Haddad C, Daneault V, Ayral V, Filiatrault M, Pastor-Bernier A, Tremblay C, Boré A, Descoteaux M, Vo A, Gagnon JF, Postuma RB, Dusek P, Marecek S, Varga Z, Klein J, Hu MT, Lehéricy S, Arnulf I, Vidailhet M, Corvol JC, ICEBERG Study Group, Rahayel S.   +21 more
europepmc   +1 more source

Basal Forebrain Volume Predicts Disease Conversion in Prodromal Synucleinopathy. [PDF]

Mov Disord Clin Pract
Churchill L, Konuri A, Ignatavicius A, Anderson J, Lewis SJG, Matar E.   +5 more
europepmc   +1 more source

Objective autonomic testing in isolated REM sleep behavior disorder: a cornerstone for clinical practice, research, and trial design. [PDF]

Sleep
Baldelli L, Provini F, Calandra-Buonaura G.   +2 more
europepmc   +1 more source

Pharmacogenetics of antidepressant response: a focused review on CYP2C19, CYP2D6, SLC6A4, and HTR2A polymorphisms. [PDF]

Front Pharmacol
Blambila L, Sabei P, Raulino VG, Herkenhoff ME.   +3 more
europepmc   +1 more source

Plasma Markers of Astrocytic and Axonal Integrity in Idiopathic/Isolated REM Sleep Behavior Disorder (iRBD) as Predictors of Dementia with Lewy Bodies. [PDF]

Mov Disord
Delva A, Zatti C, Pelletier A, Montplaisir J, Gagnon JF, Kollmorgen G, Kam-Thong T, Kustermann T, Machado V, Postuma RB.   +9 more
europepmc   +1 more source

Pharmacogenomics of CYP2D6, CYP2C19, CYP2C9, and Clinical Determinants of Fluoxetine-Norfluoxetine Pharmacokinetics in Real-World Clinical Conditions. [PDF]

Pharmaceutics
de la Cruz CG, Thomas L, Mata-Martín C, González I, LLerena A, Peñas-Lledó EM.   +5 more
europepmc   +1 more source

Longitudinal Trajectory of Multimodal Markers in a Patient with Isolated REM Sleep Behavior Disorder. [PDF]

Mov Disord
Choi S, Kim R, Woo KA, Shin JH, Yoon EJ, Kim H, Kim YK, Lee JY.   +7 more
europepmc   +1 more source